Endo to Report First Quarter 2025 Financial Results on May 7, 2025
Rhea-AI Summary
Endo (OTCQX: NDOI) has scheduled the release of its first quarter 2025 financial results for May 7, 2025, before the market opens. The company will hold a conference call at 8:30 a.m. ET on the same day.
Investors can access the audio webcast through the company's Investor Relations website at investor.endo.com under Events & Presentations. For those joining via phone, the dial-in numbers are 800-836-8184 (U.S. and Canada toll-free) and 646-357-8785 (international). Participants should connect 10 minutes before the scheduled start time. A webcast replay will be made available after the event.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, NDOI gained 0.59%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
The audio webcast may be accessed through the Investor Relations section of the Company's website at investor.endo.com under Events & Presentations. To access the call through a conference line, participants may dial 800-836-8184 (
About Endo
Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more at www.endo.com or connect with us on LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/endo-to-report-first-quarter-2025-financial-results-on-may-7-2025-302421527.html
SOURCE Endo, Inc.